HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
- PMID: 19998368
- PMCID: PMC3086139
- DOI: 10.1002/pros.21094
HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
Abstract
Background: Epidemiologic studies have shown that men with type II diabetes have a lower risk of prostate cancer than non-diabetic men. Recently, common variants in two genes, HNF1B and JAZF1, were found to be associated with both of these diseases.
Methods: We examined whether the relationship between HNF1B and JAZF1 variants and decreased prostate cancer risk may potentially be mediated through diabetes in two large prospective studies, the Cancer Prevention Study II Nutrition Cohort and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Results: Three HNF1B SNPS, rs11649743, rs4430796, and rs7501939, were associated with decreased risk of prostate cancer and were also associated, with marginal statistical significance, with increased risk of diabetes. The JAZF1 SNPs rs6968704 and rs10486567 were associated with decreased risk of prostate cancer but were not associated with diabetes. All five SNP-prostate cancer relationships did not substantially differ when the analyses were stratified by diabetic status or when diabetic status was controlled for in the model. Furthermore, the association of diabetes with prostate cancer was not altered when the SNPs were included in the logistic model.
Conclusions: These findings indicate that the HNF1B variants are directly associated with both diabetes and prostate cancer, that diabetes does not mediate these gene variant-prostate cancer relationships, and the relationship between these diseases is not mediated through these gene variants.
Figures




Similar articles
-
Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.BMC Med Genet. 2018 Jul 27;19(1):128. doi: 10.1186/s12881-018-0640-7. BMC Med Genet. 2018. PMID: 30053805 Free PMC article.
-
Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.Am J Epidemiol. 2012 Dec 15;176(12):1121-9. doi: 10.1093/aje/kws191. Epub 2012 Nov 28. Am J Epidemiol. 2012. PMID: 23193118 Free PMC article.
-
Large-scale fine mapping of the HNF1B locus and prostate cancer risk.Hum Mol Genet. 2011 Aug 15;20(16):3322-9. doi: 10.1093/hmg/ddr213. Epub 2011 May 16. Hum Mol Genet. 2011. PMID: 21576123 Free PMC article.
-
Hepatocyte nuclear factor 1 beta: A perspective in cancer.Cancer Med. 2021 Mar;10(5):1791-1804. doi: 10.1002/cam4.3676. Epub 2021 Feb 13. Cancer Med. 2021. PMID: 33580750 Free PMC article. Review.
-
Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review.World J Gastroenterol. 2015 Feb 28;21(8):2550-7. doi: 10.3748/wjg.v21.i8.2550. World J Gastroenterol. 2015. PMID: 25741167 Free PMC article. Review.
Cited by
-
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Am J Epidemiol. 2012 May 1;175(9):926-35. doi: 10.1093/aje/kwr423. Epub 2012 Mar 29. Am J Epidemiol. 2012. PMID: 22459122 Free PMC article.
-
Genome-wide association study identifies a common variant associated with risk of endometrial cancer.Nat Genet. 2011 May;43(5):451-4. doi: 10.1038/ng.812. Epub 2011 Apr 17. Nat Genet. 2011. PMID: 21499250 Free PMC article.
-
Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.BMC Med Genet. 2018 Jul 27;19(1):128. doi: 10.1186/s12881-018-0640-7. BMC Med Genet. 2018. PMID: 30053805 Free PMC article.
-
Exploring genetic loci of type 2 diabetes and cancer: a review.Endocr Oncol. 2023 Apr 25;3(1):e220094. doi: 10.1530/EO-22-0094. eCollection 2023 Jan 1. Endocr Oncol. 2023. PMID: 37529774 Free PMC article. Review.
-
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.PLoS One. 2011 Feb 24;6(2):e17142. doi: 10.1371/journal.pone.0017142. PLoS One. 2011. PMID: 21390317 Free PMC article.
References
-
- Heron MP. Deaths: Leading Causes for 2004. National Vital Statistics Reports. 2007;56(5):1–92. - PubMed
-
- Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2056–2062. - PubMed
-
- Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL, 3rd, Andriole GL. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control. 2008;19(10):1267–1276. - PMC - PubMed
-
- Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, Hollenbeck A, Schatzkin A, Leitzmann MF. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control. 2007;18(5):493–503. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical